CAAS Capital Management’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,958	Closed	-$262K	–	344
2021 Q4	$262K	Buy	+12,958	New	+$262K	0.01%	271
2020 Q4	–	Sell	-35,000	Closed	-$1.16M	–	439
2020 Q3	$1.16M	Hold	35,000	–	–	0.03%	171
2020 Q2	$1.64M	Buy	+35,000	New	+$1.64M	0.05%	101